HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Relationship between the effectiveness and dose of micafungin in the treatment of candidemia].

Abstract
The Guidelines for Management of Deep-seated Mycoses 2007 recommend the use of micafungin as a first-line agent for the treatment of candidemia. On the package insert, the recommended dose of micafungin is 50 mg/d. However, the Guidelines recommend a micafungin dose of 100-150 mg/d. In the present study, we evaluated the relationship between the effectiveness and dose of micafungin in 42 patients with candidemia who underwent treatment with micafungin. We found that the efficacy rate of micafungin at a dose of 50 mg/d was 40%, whereas that at ≥100 mg/d was 87.5%. Moreover, the treatment was more effective in patients who received ≥100 mg/d of micafungin as compared to those who received 50 mg/d of micafungin. Furthermore, we assessed the efficacy of micafungin according to the Candida species. Among all patients, the efficacy rate of micafungin was found to be lower in patients infected by Candida parapsilosis as compared to those infected by other Candida species. However, among the patients who received ≥100 mg/d of micafungin, the efficacy rate in patients infected by Candida parapsilosis was equivalent to that of patients who were infected by other Candida species. Thus, based on the results of the present study, the optimal micafungin dose for the treatment of candidemia appears to range from 100 to 150 mg/d, as recommended by the Guidelines.
AuthorsTakafumi Sugawara, Noritaka Murakami, Nobue Uetake, Shunji Matsumoto, Shinichi Miyamori, Ryouichi Okamoto, Kouichi Hiraki
JournalYakugaku zasshi : Journal of the Pharmaceutical Society of Japan (Yakugaku Zasshi) Vol. 134 Issue 3 Pg. 433-8 ( 2014) ISSN: 1347-5231 [Electronic] Japan
PMID24584025 (Publication Type: Journal Article)
Chemical References
  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Micafungin
Topics
  • Aged
  • Antifungal Agents (administration & dosage, therapeutic use)
  • Candida (drug effects)
  • Candidemia (drug therapy)
  • Dose-Response Relationship, Drug
  • Echinocandins (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Lipopeptides (administration & dosage, therapeutic use)
  • Male
  • Micafungin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: